Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 4458 of 6351
-
Gum recession fix: new platelet-rich fibrin vs. standard graft in head-to-head trial
Disease control CompletedThis split-mouth randomized clinical trial aims to compare the effectiveness of titanium-prepared platelet-rich fibrin (T-PRF) and connective tissue graft (CTG) in the treatment of Miller Class I and II gingival recession using the Vertical Incision Subperiosteal Tunnel Access (V…
Sponsor: Arab International University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Blood donors watch docudrama – will it bring them back?
Knowledge-focused CompletedA cluster pilot RCT to evaluate the effectiveness of the docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors. Secondary outcomes will be blood donor retention, attitudes, subjective norms, pe…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Sep 10, 2026 09:00 UTC
-
Can AI help create a lasting legacy for the seriously ill?
Symptom relief Recruiting nowThe purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Remote HIIT program aims to boost fitness in ANOCA patients
Knowledge-focused Recruiting nowThe main goal is to understand what causes reduced fitness in ANOCA and whether targeted exercise can help improve it. This study aims to better understand why patients with Angina and No Obstructive Coronary Artery Disease (ANOCA) have poor cardiorespiratory fitness and its eff…
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:59 UTC
-
New disposable scope aims to improve bile duct stone removal and diagnosis
Diagnosis Recruiting nowThis study plans to enroll up to 75 research subject who have a biliary disorder such as bile duct stones or intermediate biliary strictures. The purpose of this research is to assess whether the Dragonfly™ Pancreaticobiliary Scope functioned as intended in combination with the c…
Phase 4 • Sponsor: University of Colorado, Denver • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
New diabetes shot SHR-3167 enters early human testing
Disease control Recruiting nowThe objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of SHR-3167 at steady state in subjects with type 2 diabetes.
Phase 1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Wrist pain relief: new study tests blood flow trick
Symptom relief By invitation onlyThe purpose of this study is to determine the strength, pain and functional benefits of early, low-load resistance training with blood flow restriction (BFR) in ulnar-sided wrist pain treated nonoperatively with immobilization for 4-6 weeks. Hypothesis: patients in the BFR group …
Sponsor: Stanford University • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New sperm prep device could boost IVF success
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn if the LensHooke CA0 device lowers DNA fragmentation in sperm samples compared to a gradient/swim-up technique. The main questions it aims to answer are: 1. Does the LensHooke® CA0 device reduce DNA fragmentation compared to the gradi…
Sponsor: Richard Kordus, PhD, HCLD (ABB) • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:50 UTC
-
New Exosome-Based COVID booster enters human testing
Vaccine CompletedThis phase 1 clinical trial will evaluate the safety, reactogenicity, and immunogenicity of STX-S in adults who have previously received a primary series and at least one booster with an authorized or licensed SARS-CoV-2 parenteral vaccine. The study is designed as a non-randomiz…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 28, 2026 00:00 UTC
-
New HIV drug candidate GS-1219 tested in tiny early trial
Disease control Stopped earlyThis study is part of a master study. The goal of master protocol (GSUS-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that stop the virus from multiplying) affect the human immunodeficiency virus-1 (HIV-1) infection in people living with HIV (PWH). Subs…
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
AI helps doctors cut risky drugs for seniors
Disease control CompletedThe overall goal of the proposed research is to refine and adapt and perform efficacy testing of a novel reinforcement learning-based approach to personalizing EHR-based tools for PCPs on deprescribing of high-risk medications for older adults. The trial will be conducted at Atri…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New registry aims to unlock pneumonia mysteries in vulnerable patients
Knowledge-focused Recruiting nowThis multicentric, prospective study aims at: evaluating the prevalence, etiology, characteristics, and 1one-year outcomes of immunocompromised patients hospitalized for Community-Acquired Pneumonia (CAP); conducting biochemical, microbiological and genetic analysis on collected…
Sponsor: Societa Italiana di Pneumologia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
AI scribes in GP clinics: do patients like them?
Knowledge-focused CompletedThis randomised control trial study explores patient satisfaction with the use of an artificial intelligence (AI) notetaker in doctor's consultations. This involves an AI notetaker being used during doctor's consultations to summarise the conversation between the GP and patient. …
Sponsor: University of Auckland, New Zealand • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Phone calls with a pharmacist may help smokers kick the habit
Symptom relief CompletedThe goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit. The main questions it aims to answer are: * Will smokers being screened for lung cancer with low-radiation-level chest computed tomography (CT) be willing to particip…
Sponsor: University of Iowa • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New weight loss drug tested in chinese volunteers
Disease control CompletedThe study is testing a new medicine (NNC0487-0111) for weight control in Chinese people with BMI between 24 kilogram per meter square (kg/m2) and 34.9 kg/m2. The aim of the study is to see how safe the study medicine is and how it behaves in human body. Participants will either g…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New app aims to ease anxiety for heart device patients
Symptom relief Recruiting nowRole of the implantable cardioverter defibrillator (ICD) is to monitor heart rate and discharge a small electrical discharge or shock if the heart rate becomes life threatening. Patients and family members have requested more information about their ICD, how it works and how to l…
Sponsor: University of Ulster • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New study compares two root canal methods to reduce post-treatment pain
Symptom relief CompletedThis study aims to compare two commonly used root canal instrumentation systems, WaveOne (reciprocating system) and ProTaper (rotary system), in patients diagnosed with symptomatic irreversible pulpitis. Root canal treatment is performed to remove inflamed pulp tissue, disinfect …
Sponsor: Armed Forces Institute of Dentistry, Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Scientists probe hidden immune cells behind hepatitis b vaccine protection
Knowledge-focused Recruiting now296 million people worldwide are infected with the hepatitis B virus (HBV), despite the existence of an effective prophylactic vaccine. Current treatments (nucleoside analogues and pegylated interferon-α) do not prevent chronic hepatitis B (CHB) patients from developing liver fib…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug MAR002 takes first step toward treating acromegaly
Disease control Recruiting nowEvaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Phase 1 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could your own tooth help a dental implant heal faster?
Disease control Recruiting nowThis randomized clinical study aims to evaluate the effect of autologous demineralized dentin graft (ADDG) with or without melatonin gel on the osseointegration of immediately placed dental implants in the maxillary premolar region. Thirty patients requiring extraction and immedi…
Sponsor: Suez Canal University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC